| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EVI2A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | CCL22 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AC092159.1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PLD4 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | TMEM97 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | LDLRAD1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | TMEM104 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | LA16c-431H6.6 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | HMSD | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AC007557.5 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
